Obserwuj
Lajos Kemény
Lajos Kemény
HCEMM
Zweryfikowany adres z med.u-szeged.hu - Strona główna
Tytuł
Cytowane przez
Cytowane przez
Rok
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded …
A Blauvelt, M de Bruin-Weller, M Gooderham, JC Cather, J Weisman, ...
The Lancet 389 (10086), 2287-2303, 2017
11502017
IL-31: a new link between T cells and pruritus in atopic skin inflammation
E Sonkoly, A Muller, AI Lauerma, A Pivarcsi, H Soto, L Kemeny, H Alenius, ...
Journal of Allergy and Clinical Immunology 117 (2), 411-417, 2006
11042006
Definition of treatment goals for moderate to severe psoriasis: a European consensus
U Mrowietz, K Kragballe, K Reich, P Spuls, CEM Griffiths, A Nast, J Franke, ...
Archives of dermatological research 303, 1-10, 2011
10822011
European S3-guidelines on the systemic treatment of psoriasis vulgaris
D Pathirana, AD Ormerod, P Saiag, C Smith, PI Spuls, A Nast, J Barker, ...
Journal of the European Academy of Dermatology and Venereology 23 (SUPPL. 2 …, 2009
9552009
European S3-guidelines on the systemic treatment of psoriasis vulgaris-update 2015-short version-EDF in cooperation with EADV and IPC
A Nast, P Gisondi, AD Ormerod, P Saiag, CH Smith, PI Spuls, ...
Journal of the European Academy of Dermatology and Venereology 29 (12), 2277 …, 2015
5322015
Expression and function of Toll‐like receptors 2 and 4 in human keratinocytes
A Pivarcsi, L Bodai, B Réthi, A Kenderessy‐Szabó, A Koreck, M Széll, ...
International immunology 15 (6), 721-730, 2003
4802003
Distinct strains of Propionibacterium acnes induce selective human β-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors
I Nagy, A Pivarcsi, A Koreck, M Széll, E Urbán, L Kemény
Journal of Investigative Dermatology 124 (5), 931-938, 2005
4512005
Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes
I Nagy, A Pivarcsi, K Kis, A Koreck, L Bodai, A McDowell, H Seltmann, ...
Microbes and infection 8 (8), 2195-2205, 2006
4452006
Extreme vulnerability of IDH1 mutant cancers to NAD+ depletion
K Tateishi, H Wakimoto, AJ Iafrate, S Tanaka, F Loebel, N Lelic, ...
Cancer cell 28 (6), 773-784, 2015
4032015
Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne
DM Thiboutot, B Dréno, A Abanmi, AF Alexis, E Araviiskaia, MIB Cabal, ...
Journal of the American Academy of Dermatology 78 (2), S1-S23. e1, 2018
3632018
308 nm UVB excimer laser for psoriasis
B Bonis, L Kemény, A Dobozy, Z Bor, G Szabó, F Ignacz
The Lancet 350 (9090), 1522, 1997
2841997
Identification and characterization of a novel, psoriasis susceptibility-related noncoding RNA gene, PRINS
E Sonkoly, Z Bata-Csorgo, A Pivarcsi, H Polyanka, A Kenderessy-Szabo, ...
Journal of Biological Chemistry 280 (25), 24159-24167, 2005
2702005
Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B
Z Novák, B Bónis, E Baltás, I Ocsovszki, F Ignácz, A Dobozy, L Kemény
Journal of Photochemistry and Photobiology B: Biology 67 (1), 32-38, 2002
2592002
MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2
N Xu, P Brodin, T Wei, F Meisgen, L Eidsmo, N Nagy, L Kemeny, M Ståhle, ...
Journal of Investigative Dermatology 131 (7), 1521-1529, 2011
2482011
CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation
M Gombert, MC Dieu-Nosjean, F Winterberg, E Bünemann, RC Kubitza, ...
The Journal of Immunology 174 (8), 5082-5091, 2005
2472005
Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human β-defensin-2 in vaginal epithelial cells
A Pivarcsi, I Nagy, A Koreck, K Kis, A Kenderessy-Szabo, M Szell, ...
Microbes and infection 7 (9-10), 1117-1127, 2005
2262005
Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double‐blind, placebo‐controlled trials
MEB Clowse, DJ Wallace, RA Furie, MA Petri, MC Pike, P Leszczyński, ...
Arthritis & rheumatology 69 (2), 362-375, 2017
2192017
Alcohol disrupts levels and function of the cystic fibrosis transmembrane conductance regulator to promote development of pancreatitis
J Maléth, A Balázs, P Pallagi, Z Balla, B Kui, M Katona, L Judák, I Németh, ...
Gastroenterology 148 (2), 427-439. e16, 2015
2102015
The role of innate immunity in the pathogenesis of acne
A Koreck, A Pivarcsi, A Dobozy, L Kemeny
Dermatology 206 (2), 96-105, 2003
2072003
MiR‐21 is up‐regulated in psoriasis and suppresses T cell apoptosis
F Meisgen, N Xu, T Wei, PC Janson, S Obad, O Broom, N Nagy, ...
Experimental dermatology 21 (4), 312-314, 2012
2002012
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20